GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 833 filers reported holding GLAXOSMITHKLINE PLC in Q2 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $270,000 | -71.5% | 7,178 | -69.1% | 0.05% | -77.4% |
| Q2 2020 | $948,000 | +149.5% | 23,233 | +131.8% | 0.23% | +53.3% |
| Q1 2020 | $380,000 | -29.2% | 10,023 | -12.3% | 0.15% | -11.8% |
| Q4 2019 | $537,000 | +10.3% | 11,427 | +0.2% | 0.17% | +1.8% |
| Q3 2019 | $487,000 | +2.5% | 11,409 | -4.0% | 0.17% | -0.6% |
| Q2 2019 | $475,000 | -0.2% | 11,879 | +4.3% | 0.17% | -5.6% |
| Q1 2019 | $476,000 | +16.4% | 11,384 | +6.3% | 0.18% | -9.6% |
| Q4 2018 | $409,000 | -21.9% | 10,713 | -17.9% | 0.20% | -10.0% |
| Q3 2018 | $524,000 | +5.2% | 13,048 | +5.7% | 0.22% | +4.8% |
| Q2 2018 | $498,000 | +4.8% | 12,345 | +3.2% | 0.21% | -18.0% |
| Q1 2018 | $475,000 | +20.9% | 11,961 | +7.9% | 0.26% | +30.8% |
| Q4 2017 | $393,000 | – | 11,090 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |